Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

EU-Funded ARGUGRID Project Adopts InforSense® Integrative Analytics Technology

Published: Wednesday, October 04, 2006
Last Updated: Wednesday, October 04, 2006
Bookmark and Share
InforSense to provide integrative analytics environment to support collaborative decision making.

InforSense Ltd. has announced that the company has been selected as a technology partner in the €2M European Union (EU) funded ARGUGRID project.

The project is a collaborative effort between eight partners from five countries and is funded by the IST Grid technologies program.

The goal of ARGUGRID is to develop the next generation service-oriented computing platform for scientific and business applications.

Based on semantic web and agent-based technologies, the project is developing techniques for supporting dynamic service selection, composition and optimization by applying advanced logical reasoning over service semantics.

The development of such technology is key to the success of large-scale B2B collaborations within a service-oriented computing framework. 

"InforSense is pleased to receive support from the EU and their recognition of our technical excellence," said Prof. Yike Guo, Founder and Chief Executive Officer of InforSense.

"InforSense is committed to advanced computation research, and we believe that the combination of semantic web technology, agent computing and logical reasoning is key to evolving our industry-leading workflow technology for service composition in complex business applications."

"We believe InforSense workflow technology is the obvious choice to meet the needs and expectations of the EU in service-oriented computing," said Dr. Francesca Toni, ARGUGRID Project Coordinator.

"The proven flexibility inherent in InforSense KDE workflow technology, coupled with the ability for users to communicate in a highly secure environment is essential to the success of this project."

InforSense KDE will provide the central mechanism for computing services composition.

Enhanced by logical reasoning technology, which will be developed in the project, the InforSense workflow engine will support a paradigm for autonomic, or self-managing, service composition.

In addition, InforSense will integrate technology developed from the project into its upcoming product releases. 

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

InforSense Partners with U.K.’s Leading Institutions to Combat Alzheimer’s Disease
Translational research solution to help accelerate early diagnosis and personalized medicine treatments.
Wednesday, December 03, 2008
InforSense GenSense Achieves GeneChip-compatible™ Status with the Affymetrix GeneChip® Microarray Platform
Affymetrix has become a member of InforSense’s Open Workflow Partner Network joining over 40 other partners in the program.
Tuesday, August 07, 2007
InforSense® Announces Conference Series
The InforSense Users Conference will provide opportunity to learn how InforSense KDE is being used to facilitate business-critical decision-making across a variety of industries.
Tuesday, November 14, 2006
$10 Million Investment to Boost InforSense Expansion
Fleming Family & Partners Private Equity and Imperial Innovations lead strategic investment round.
Tuesday, October 10, 2006
InforSense® Appoints David Hadfield as Chief Operating Officer
Former Spotfire executive strengthens InforSense management team.
Tuesday, October 03, 2006
Bayer Selects InforSense for Next Generation Integrative Analytics Infrastructure
InforSense KDE, will provide Bayer with a flexible rapid application development platform to optimize their drug discovery decision-making.
Friday, September 16, 2005
Scientific News
Genetic Defences of Bacteria Don’t Aid Antibiotic Resistance
Genetic responses to the stresses caused by antibiotics don’t help bacteria to evolve a resistance to the medications, according to a new study by Oxford University researchers.
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Snapshot Turns T Cell Immunology on its Head
New research may have implications for 1 diabetes sufferers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
Horse Illness Shares Signs of Human Disease
Horses with a rare nerve condition have similar signs of disease as people with conditions such as Alzheimer’s, a study has found.
How a Molecular Motor Untangles Protein
Diseases such as Alzheimer’s, Parkinson’s and prion diseases, all involve “tangled” proteins.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos